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Abstract: 
Prediction of peptides binding to HLA (human leukocyte antigen) finds application in peptide vaccine design. A number of 
statistical and structural models have been developed in recent years for HLA binding peptide prediction. However, a 
Bayesian Network (BNT) model is not available. In this study we describe a BNT model for HLA-A2 binding peptide 
prediction. It has been demonstrated that the BNT model allows up to 99% accurate identification of the HLA-A2 binding 
peptides and provides similar prediction accuracy compared to HMM (Hidden Markov Model) and ANN  (Artificial Neural 
Network). At the same time, it has been shown that the BNT has that advantage that it allows more accurate performance for 
smaller sets of empirical data compared to the HMM and the ANN methods. When the size of the training set has been 
reduced to 40% from the original data, the identification of the HLA-A2 binding peptides by the BNT, ANN and HMM 
methods produced ARoc (area under receiver operating characteristic) values 0.88, 0.85, 0.85 respectively. The results of 
the work demonstrate certain advantages of using the Bayesian Networks in predicting the HLA binding peptides using 
smaller datasets.  
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Background: 
The recognition of foreign antigen peptides by the host 
HLA (human leukocyte antigen) molecules is critical for 
T mediated immune response. [1,2] There are two major 
classes of the HLA: class I molecules bind peptides 
originating from endogenous pathogenic proteins while 
the class II bind peptides derived from exogenous 
antigens. [1,2,3] The HLA class I and class II usually 
bind antigenic peptides consisting of 8-11 and 13-23 
residues, respectively (some class II HLA bind > 40 
residues long peptides). The binding is usually 
characterized by very high selectivity achieved through 
the interaction of the HLA with several critical 
(anchoring) residues of a peptide. Thus, despite the fact 
that biodegradation of antigenic proteins can 
theoretically produce a very large diversity of peptides, 
the actual number of them selectively bound to a specific 
HLA allele is limited. [4,5] This makes it not trivial and 
a very important goal to theoretically identify those 
specific fragments of protein sequences that are capable 
of selective interaction with specific HLA allele. It is 
believed that the ability of predicting HLA binding can 
not only provide a valuable insight into adaptive 
immunity but is also an essential step of ‘in silico’ 
vaccine development. [3] In recent years, a number of 
theoretical methods for predicting HLA binding have 
been reported. [1-4] Conventionally, these tools could be 
divided into three major groups: profile- and matrix-
based approaches [6], methods utilizing the Artificial 
Neural Networks (ANN) [6,7]  and those using the 
Hidden Markov Model (HMM). [8]  
 
The profile- and matrix-operating models are based on 
the notion (derived by the analysis of crystal structures 
of peptide-HLA complexes) that the binding energy for 
individual residue within a peptide does not depend on 
the effects of the neighbouring amino acids. [6, 9] Thus, 
the corresponding methods operate by various additive 
scoring schemes to evaluate the likelihood of a given 
peptide to bind to a particular HLA allele. Such 
simplification allows fast processing of large amounts of 
data but sometimes accounts for the low accuracy 
compared to non-linear approximations such as Artificial 
Neutral Networks (ANN) or the Hidden Markov Model 
(HMM). [6, 8]  
 
In the current study, we evaluate the previously 
unreported Bayesian Network (BNT) approach as 
another suitable method for modeling the HLA binding 
and compare the performance of the BNT with the 
results from the ANN and HMM solutions. The 
successful applications of the ANNs for prediction of the 
HLA peptides have been demonstrated in numerous 
studies. [6-8] Usually, the ANN based methods produces 
up to 80% accuracy in distinguishing the HLA binders 
from non-binders. At the same time, the ANN 
approximation is not suitable for processing peptides of 
varying length.  
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On another hand, this problem can be resolved by 
utilizing the Hidden Markov Model which allow up to 
85% accuracy in discriminating the HLA binding 
peptides.  [8] Being somewhat more accurate than the 
ANN-based methods, the HMM has the disadvantage of 
being more computationally demanding. Moreover, the 
Hidden Markov Model can only consider the mutual 
influence of adjacent residues but cannot account for 
possible distant interaction between non-neighbouring 
residues in a peptide. Therefore, the existing 
computational tools allow rather accurate theoretical 
prediction of the HLA binding peptides (for certain HLA 
alleles) given that there is enough experimental data 
available to train the corresponding machine learning 
models. Here, we describe a BNT model using smaller 
empirical datasets compared to training requirements for 
ANN and HMM. 
 
Methodology: 
Dataset: 
Binders:  We derived a set of 244 HLA-A2 binding 
peptides from MHCPEP and SYFPEITHI databases. [6, 
8, 10] Non-binders: A set of 464 non-binding peptides 
required for adequate model training have been 
randomly generated from a human albumin sequence. 
The size of the non-binders was chosen so as to keep the 
binder – non-binder ratio to 1:2. Over training: Peptides 
used for training were carefully curated to avoid over 
training by eliminating redundant peptides such that no 
two peptides shared more than 4 residues. 
 
Software used in the analysis: 
Several open source and commercial software products 
have been used in this study. The ANN (a fully 
connected 3-layer back-propagation configuration 
trained on the generalized delta rule) has been built and 
manipulated within the Stuttgart Neural Network 
Simulator (SNNS) package. The input and output layers 
consisted of 180 nodes and 1 node, respectively. The 
number of the hidden layer nodes has been tested in the 
range of 2 to 50. The Bayesian Network has been built 
with the WEKA machine-learning software and the 
Hidden Markov Model was created with the MATLAB 
(simulation and modelling software) HMM toolkit. 
 
ANN (Artificial Neural Networks): 
An application of ANN  for prediction of class I HLA 
binding has been described by Brusic and co-authors. [6] 
The developed ANN-based method uses the machine 
learning algorithm to train the HLA binding patterns in 
peptide residues. The typical configuration of the ANN 
adopted for the HLA binding prediction represents a 
three layer Neural Network operating on the binary 
input. Within this approximation, each HLA binding 
peptide consisting of nine residues (typical for class I 
HLA) is represented as a string of 180 binary numbers 
(zeros and ones) serving as the input of the ANN. This 
corresponding 180-elements vector is formed by 9 
blocks of 20 numbers where each block represents a 
consequent position on a peptide and every number in 
the block of 20 designates the presence or absence of 
specific the amino acid residue. The hidden nodes of the 
ANN play the role of free optimisation storing the 
inferred patterns emerging from the input data. Number 
of hidden nodes can usually be optimised during the 
ANN training and the output of the three layers ANN is 
constituent of a single node providing the binder/non-
binder discrimination information. 
 
HMM (Hidden Markov Model): 
The HMM approach describes an abstract statistical 
system as a number of hypothetical states connected by 
the transition probabilities. Thus, the problem of 
formalization of the HLA binding is a ‘natural’ task for 
the HMM which treats a string of residues in a peptide as 
a Markov Chain terminated by its START and END 
Markov states. A peptide represented in HMM includes 
20 Matching states (reflecting possible variations of 
amino acids) as well as 20 Deletion and 20 Insertion 
states altogether instructing the HMM algorithm to 
extract the binding patterns from the empirical HLA 
binding data. The HMM defines the probabilities 
included into the matching states on the basis of the 
experimental frequencies of particular residue in a given 
peptide position during training of empirical inputs (sets 
of peptides with experimentally pre-determined binding 
or non-binding character). The Insertion state of the 
Markov Chain represents a logical operation for 
introducing an additional residue into the construction of 
a pattern with uniform probabilities and the Deletion 
states are defined within the HMM without assigning any 
probabilistic properties. HMM utilizes the Baum-Welch 
[8] algorithm optimizing the transition probabilities from 
one state to another beginning from the Start state of the 
Markov Chain and then chooses the next state of the 
system depending on the transition probabilities of the 
consequent chain edges. This process repeats until the 
transition reaches the End state which leads to the 
generation of multiple patterns (sequences of states) each 
reflecting the probability of the studied peptide to be a 
HLA binder. More detailed description of the HMM 
method for predicting HLA binding peptides is described 
elsewhere. [8] 
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BNT (Bayesian Network):  
The Bayesian Network method processes experimental 
information differently compared to conventional 
statistical approaches. Instead of using pre-defined 
analytical functions the BNT attempts to establish an 
optimal statistical model to fit experimental data. The 
Bayesian approach has found a broad application in 
those areas of data analysis where there is a need for 
extracting complex patterns from sizable amounts of 
information with significant levels of noise. The 
Bayesian method has been successfully employed for the 
SAGE data analysis, for modeling genetic regulatory 
interactions [11], for solving some protein folding 
problems [12] and for text processing and diagnostics. 
[13] One of the basic Bayesian definitions is prior 
information P(H) where H is a model/hypothesis and 
P(H) is probability of a model to be true. In the context 
of predicting the HLA binding, as a prior information 
P(H) we can consider the assumption that any peptide 
can theoretically be a HLA binder. In other words, the 
initial probability P(H) for an arbitrary peptide to bind to 
a particular HLA allele is 50% (a chance probability 
which will change in a recurrent manner during the 
Bayesian optimisation). Another definition of the 
Bayesian analysis is a likelihood function P(D|H) 
reflecting the probability of obtaining the observed 
experimental data (D). This function is not pre-set prior 
the analysis but is estimated during the BNT 
optimisation. The third Bayesian category is the degree 
of plausibility P(H|D) (sometimes called posterior 
probability of initial hypothesis) which can be calculated 
using the Bayesian Theorem stated as follows in 
equation 1. Equation 1 is p(H|D ) = p( D|H) p(H)/p(D), 
where p(D) is the normalization factor. The Bayesian 
Network represents an application of the Bayesian theory 
which formalizes the joint distribution over a set of 
random variables X = {X1,..., Xn} as a product of 
conditional probabilities. An abstract Bayesian network 
can be defined by a graphical structure M combining a 
family F of conditional probability distributions F= {P 
(Xi | q)}, in turn depending on the vector of parameters q 
= {pa[Xi ]}. The graphical structure M can be illustrated 
as set of nodes V and directed edges E which can 
connect any pair of nodes where the nodes V correspond 
to random variables and the edges indicate conditional 
dependence relations among them (Figure 1A). Here, we 
describe the use of Bayesian Network for the prediction 
of HLA binding peptides. Peptides consisting of nine 
residues can be described by 180 variables each 
reflecting a probability to have a defined residue type at 
a defined position of a HLA binding peptide. The 
relationships between these 180 variables can be 
optimized within the BNT methodology for peptides in 
the training set to yield the posterior probabilities p(H|D) 
according to equation 1. Figure 1A illustrates that the 
BNT can capture mutual influences among amino acids 
in a HLA binding peptide by representing it as a directed 
graph consisting of edges Xi. The BNT can operate on 
such graph on the basis of the observed frequencies of 
certain amino acids at defined positions of the peptides 
capable of binding to the HLA molecule. Accordingly, 
the joint probability for a given peptide to be a binder 
can be estimated by the BNT as given in equation 2. 
Equation 2 is P(X1, X2, . . . ,Xn) = P(X1  | pa[X1 ]) 
*P(X2  | pa[X2 ]) *......*P(Xn  | pa[Xn]) where, where 
P(Xi |pa[Xi ]) = K1* P(Xi | pa 1 [Xi ])  +  K2* P(Xi | pa 2 
[Xi ])  + K3* P(Xi | pa 3 [Xi ])+… represents a sum of 
conditional probabilities and Kj is a weight coefficient. 
The entity P(Xi|pa[Xi]) in equation 2 corresponds to the 
conditional probability which represents the influence of 
variable Xi on a peptide binding ability.  It should be 
noted that the vector pa[Xi]={pa1[Xi], pa2[Xi], ..} is 
represented in Figure 1A by the graph edges. 
 
Results and Discussion: 
Performance of BNT, ANN and HMM in original set: 
A total of 708 peptides are separated into training and 
testing groups (in the proportion of 9:1) each containing 
both binding and non-binding peptides (the corresponding 
sets are given in Appendix 1). The very same training and 
testing sets are used to train and evaluate the ANN, HMM 
and BNT models for distinguishing the HLA-A2 
interacting peptides. A constant cutoff values 1 and 0 to the 
HLA-A2 binding and non-binding peptides in the training 
set was assigned. It has been observed that both ANN and 
the HMM required less than 200 training cycles to achieve 
maximal predictive accuracy. It has also been established 
that by gradually changing the number of ANN hidden 
nodes from 2 to 50, the predictive ability of the network 
(the ANN learning rate was kept 0.2 with the 0.02 shift) is 
not significantly influenced. The processing of the data by 
BNT for each peptide in the training set yielded the 
resulting probability value P(X1, X2, . . . , Xn). The 
corresponding parameters estimated by equation 2 can be 
found in Table 1 (see Additional file 1). Corresponding 
outputs from ANN and HMM are also given. Each peptide 
in Table 1 has been classified as the HLA-A2 binder if the 
corresponding BNT joint probability P(X1, X2,  . . . , Xn) 
exceeded 50%. The outputs from HMM and ANN have 
also been characterized by applying 50% cut-off. The 
predictive power of all three methods has been assessed by 
processing the testing set (67 peptides) through the pre-
trained models. Subsequently, FP (false positives), FN 
(false negatives), TP (true positives) and TN (true 
negatives) were estimated. Then, sensitivity, specificity, 
percentage of correct predictions and Matthews Correlation 
Coefficients ((Mc) = {TP*TN-
FP*FN}/{(TN+FN)(TN+FP)(TP+FN)(TP+FP)}
1/2 ) were 
also calculated (Table 1). Results show that ANN, HMM 
and BNT produced prediction accuracy for testing and 
training sets. However, BNT outperformed ANN by 8% for 
HLA-A2 peptide binding prediction. Results of the ARoc 
analysis for the three models are also presented in Table 1. Bioinformation by Biomedical Informatics Publishing Group  open access 
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Set 1 (73 peptides)  Set 2 (635 peptides)  Prediction parameter 
ANN HMM  BNT  ANN  HMM  BNT 
True Positives  17  21  24  191  193  194 
True Negatives  42  44  45  386  390  392 
False Positives  6  4  3  30  26  24 
False Negatives  8  4  1  28  26  25 
Matthew Coefficient   0.73 0.85  0.86  0.78  0.86  0.89 
Specificity 0.91  0.92 0.94  0.93  0.94  0.94 
Sensitivity 0.68  0.84  0.96  0.87  0.88  0.89 
Correct  predictions 0.89  0.93 0.95  0.91  0.93  0.95 
ARoc performance 
Training/Testing set  
separation  ANN HMM  BNT 
0.4 / 0.6  0.856  0.860  0.880 
0.5 / 0.5  0.873  0.880  0.901 
0.6 / 0.4  0.932  0.920  0.940 
0.7/ 0.3  0.962  0.950  0.960 
0.8 / 0.2  0.985  0.992  0.980 
0.9 / 0.1  0.992  0.998  0.990 
 
Table 1: Performance of different models in varying datasets is given. 
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Figure 1: (A) Representation of a nine residue long peptide by the Bayesian Network. (B) Dependence between the 
estimated ARoc parameter by ANN, HMM and BNT with training and testing set. (C) Dependence between the prediction 
accuracy estimated by ANN, HMM and BNT with training set size. 
 
Performance of BNT, ANN and HMM in reduced set 
The ARoc performances of the three models for varying 
proportions of training and testing set are also presented 
in Table 1 and Figure 1B. The ARoc for all the three 
models are very high for large proportions of training 
sets (80% and 90%). However, the ARoc for BNT is 
higher than ANN and HMM for low proportions of 
training sets (40%-60%). This suggests that BNT out 
performs ANN and HMM when lower proportions of 
training set are used and is therefore suitable for 
modeling when dataset size is limited (as low as 40%). 
The corresponding dependence between prediction 
accuracies and proportions of training to testing datasets 
is given in Figure 1C. Figure 1C suggests that the 
performance of all the methods is comparable when the 
size of the training sets is sufficiently large. However, 
when the training set is reduced the BNT provide more 
accurate predictions. It should be noted however, that the 
BNT is computationally intensive and may be less 
applicable for processing very large amounts of data. 
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Conclusion: 
HLA binding peptide prediction finds application in 
vaccine design. However, the prediction of HLA binding 
peptides is not trivial. Here, we discussed the 
performance of ANN, HMM, BNT models for HLA-A2 
binding peptide prediction. The prediction accuracy of 
ANN, HMM, BNT are similar when large training sets 
are used. Nonetheless, the BNT model performed better 
than ANN and HMM even when the training set is 
reduced to 40% of the original size. 
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